Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of HER Receptor Family as Indicator of Prognosis and Drug Responsiveness in Locally Advanced Prostate Cancer

NCT00418080 is registered in ClinicalTrials.gov with University of L'Aquila as lead sponsor.

NCT NCT00418080
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00418080 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of HER Receptor Family as Indicator of Prognosis and Drug Responsiveness in Locally Advanced Prostate Cancer
Lead sponsor
University of L'Aquila
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2002
Completion date
December 31, 2006
Enrollment
86
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer